The Rhodococcus sp. Cocaine Esterase: A Bacterial Candidate for Novel Pharmacokinetic-based Therapies for Cocaine Abuse

IUBMB Life

Volumn 55, Issue 7, 2003, Pages 397-402

  Ascenzi, Paolo ^a   Clementi, Emilio ^b,c,d   Polticelli, Fabio ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

^d UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Cocaine binding antibodies; Cocaine binding catalytic antibodies; Cocaine metabolism; Human liver carboxylesterase 1; Human liver carboxylesterase 2; Human plasma butyrylcholinesterase; Rhodococcus sp. esterase

Indexed keywords

CARBOXYLESTERASE; CARBOXYLESTERASE 1; CARBOXYLESTERASE 2; CATALYTIC ANTIBODY; CENTRAL STIMULANT AGENT; CHOLINESTERASE; COCAINE; ENZYME; UNCLASSIFIED DRUG;

CATALYSIS; COCAINE DEPENDENCE; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG RECEPTOR BINDING; REVIEW; RHODOCOCCUS; TOXICOKINETICS;

CARBOXYLESTERASE; CARBOXYLIC ESTER HYDROLASES; CATALYSIS; COCAINE; COCAINE-RELATED DISORDERS; HUMANS; HYDROLYSIS; LIVER; MODELS, CHEMICAL; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RHODOCOCCUS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); RHODOCOCCUS; RHODOCOCCUS SP.; UNCULTURED ACTINOMYCETE;

EID: 0142119565     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/1521654031000138541     Document Type: Review

References (74)

1. Novak, M., Salemink, C. A., and Khan, I. (1984) Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatense. J. Ethnopharmacol. 10, 261-274.
2. Di Paolo, T., Rouillard, C., Morissette, M., Levesque, D., and Bedard, P. J. (1989) Endocrine and neurochemical actions of cocaine. Can. J. Physiol. Pharmacol. 67, 1177-1181.
3. Barroso-Moguel, R., Villeda-Hernandez, J., and Mendez-Armenta, M. (1991) Medical causes and effects of cocaine abuse. Arch. Med. (Mex.) 22, 3-8.
4. Nathanson, J. A., Hunnicutt, E. J., Kantham, L., and Scavone, C. (1993) Cocaine as a naturally occurring insecticide. Proc. Natl. Acad. Sci. USA 90, 9645-9648.
5. Welder, A. A., Grammas, P., and Melchert, R. B. (1993) Cellular mechanisms of cocaine cardiotoxicity. Toxicol. Lett. 69, 227-238.
6. Withers, N. W., Pulvirenti, L., Koob, G. F., and Gillin, J. C. (1995) Cocaine abuse and dependence. J. Clin. Psychopharmacol. 15, 63-78.
7. Breiter, H. C., Gollub, R. L., Weisskoff, R. M., Kennedy, D. N., Makris, N., Berke, J. D., Goodman, J. M., Kantor, H. L., Gastfriend, D. R., Riorden, J. P., et al. (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19, 591-611.
8. Carroll, F. I., Howell, L. L., and Kuhar, M. J. (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J. Med. Chem. 42, 2721-2736.
9. De Prada, P., Winger, G., and Landry, D. W. (2000) Application of artificial enzymes to the problem of cocain. Ann. N. Y. Acad. Sci. 909, 159-169.
10. Howell, L. L., and Wilcox, K. M. (2001) The dopamine transporter and cocaine medication development: drug self-administration nonhuman primates. J. Pharmacol. Exp. Ther. 298, 1-6.
11. Lange, R. A., and Hillis, L. D. (2001) Cardiovascular complications of cocaine use. N. Engl. J. Med. 345, 351-357.
12. Kreek, M. J., LaForge, K. S., and Butelman, E. (2002) Pharmacotherapy of addictions. Nat. Rev. Drug. Discov. 1, 710-726.
13. Johanson, C. E., and Fischman, M. W. (1989) The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41, 3-52.
14. Kuhar, M. J., Ritz, M. J., and Boja, J. W. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299-302.
15. Rocha, B. A., Fumagalli, F., Gainetdinow, R. R., Jones, S., Ator, R., Giros, B., Miller, G. W., and Caron, M. C. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci. 1, 132-137.
16. Reith, M. E., Xu, C., and Chen, N. H. (1997) Pharmacology and regulation of the neuronal dopamine transporter. Eur. J. Pharmacol. 324, 1-10.
17. Dackis, C. A., and O'Brien, C. P. (2001) Cocaine dependence: a disease of the brain's reward centers. J. Subst. Abuse Treatment 21, 111-117.
18. Carboni, E., Imperato, A., Perezzani, L., and Di Chiara, G. (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28, 653-661.
19. Ritz, M. C., Lamb, R. J., Goldberg, S. R., and Kuhar, M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
20. Volkow, N. D., Fowler, J. S., and Wang, G. J. (1999) Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J. Psychopharmacol. 13, 337-345.
21. Winder, D. G., Egli, R. E., Schramm, N. L., and Matthews, R. T. (2002) Synaptic plasticity in drug reward circuitry. Curr. Mol. Med. 2, 667-676.
22. Higgins, S. T., and Katz, J. L., Eds (1998) Cocaine Abuse Research: Pharmacology. Behaviour, and Clinical Applications. Academic Press, New York.
23. Ritz, M. C., and George, F. R. (1993) Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J. Pharmacol. Exp. Ther. 264, 1333-1343.
24. 1 receptors in cocaine lethality. Pharmacol. Biochem. Behav. 51, 521-523.
25. Gantenberg, N. S., and Hageman, G. R. (1992) Cocaine-enhanced arrhythmogenesis: neural and nonneural mechanisms. Com. J. Physiol. Pharmacol. 70, 240-246.
26. Deng, S.-X., Bharat, N., Fischman, M. C., and Landry, D. W. (2002) Covalent modification of proteins by cocaine. Proc. Natl. Acad. Sci. USA 99, 3412-3416.
27. Carrera, M. R. A., Ashley, J. A., Parsons, L. H., Wirsching, P., Koob, G. F., and Janda, K. D. (1995) Suppression of psychoactive effects of cocaine by active immunization. Nature 378, 727-730.
28. Carrera, M. R. A., Ashley, J. A., Zhou, B., Wirsching, P., Koob, G. F., and Janda, K. D. (2000) Cocaine vaccines: antibody protection against relapse in a rat model. Proc. Natl. Acad. Sci. USA 97, 6202-6206.
29. Carrera, M. R. A., Ashley, J. A., Wirsching, P., Koob, G. F., and Janda, K. D. (2001) A second-generation vaccine protects against the psychoactive effects of cocaine. Proc. Natl. Acad. Sci. USA 98, 1988-1992.
30. Self, D. W. (1995) Drug addiction: cocaine abuse takes a shot. Nature 378, 666-667.
31. Koetzner, L., Deng, S., Sumpter, T. L., Weisslitz, M., Abner, R. T., Landry, D. W., and Woods, J. H. (2001) Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. J. Pharmacol. Exp. Ther. 296, 789-796.
32. Larsen, N. A., Zhou, B., Heine, A., Wirsching, P., Janda, K. D., and Wilson, I. A. (2001) Crystal structure of a cocaine-binding antibody. J. Mol. Biol. 311, 9-15.
33. Kosten, T. R., Rosen, M., Bond, J., Settles, M., Roberts, J. S., Shields, J., Jack, L., and Fox, B. (2002) Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 20, 1196-1204.
34. Landry, D. W., Zhao, K., Yang, G. X., Glickman, M., and Georgiadis, T. M. (1993) Antibody-catalyzed degradation of cocaine. Science 259, 1899-1901.
35. Yang, G., Chun, J., Arakawa-Uramoto, H., Wang, X., Gawinowicz, M. A., Zhao, K., and Landry, D. W. (1996) Anti-cocaine catalytic antibodies: a synthetic approach to improved antibody diversity. J. Am. Chem. Soc. 118, 5881-5890.
36. Mattes, C. E., Lynch, T. J., Syngh, A., Bradley, R. M., Kellaris, P. A., Brady, R. O., and Dretchen, K. L. (1997) Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol. Appl. Pharmacol. 145, 372-380.
37. Pindel, E. V., Kedishvili, N. Y., Abraham, T. L., Brzezinski, M. R., Zhang, J., Dean, R. A., and Bosron, W. F. (1997) Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem. 272, 14769-14775.
38. Mets, B., Winger, G., Cabrera, C., Seo, S., Jamdar, S., Yang, G., Zhao, K., Briscoe, R. J., Almonte, R., Woods, J. H., et al. (1998) A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proc. Natl. Acad. Sci. USA 95, 10176-10181.
39. Xie, W., Altamirano, C. V., Bartels, C. F., Speirs, R. J., Cashman, J. R., and Lockridge, O. (1999) An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient. Mol. Pharmacol. 55, 83-91.
40. Zhang, J., Burnell, J. C., Dumaual, N., and Bosron, W. F. (1999) Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J. Pharmacol. Exp. Ther. 290, 314-318.
41. Ashani, Y. (2000) Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugs. Drug. Dev. Res. 50, 298-308.
42. Baird, T. J., Deng, S. X., Landry, D. W., Winger, G., and Woods, J. H., (2000) Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J. Pharmacol. Exp. Ther. 295, 1127-1134.
43. Bresler, M. M., Rosser, S. J., Basran, A., and Bruce, N. C. (2000) Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl. Environ. Microbiol. 66, 904-908.
44. Cashman, J. R., Berkman, C. E., and Underiner, G. E. (2000) Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. J. Pharmacol. Exp. Ther. 293, 952-961.
45. Briscoe, R. J., Jeanville, P. M., Cabrera, C., Baird, T. J., Woods, J. H., and Landry, D. W. (2001) A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. Int. Immunopharmacol. 1, 1189-1198.
46. Matsushita, M., Hoffman, T. Z., Ashley, J. A., Zhou, B., Wirsching, P., and Janda, K. D. (2001) Cocaine catalytic antibodies: the primary importance of linker effects. Bioorg. Med. Chem. Lett. 11, 87-90.
47. Bosron, W. F., and Hurley, T. D. (2002) Lessons from a bacterial cocaine esterase. Nat. Struct. Biol. 9, 4-5.
48. Larsen, N. A., Turner, J. M., Stevens, J., Rosser, S. J., Basran, A., Lerner, R. A., Bruce, N. C., and Wilson, I. A. (2002) Crystal structure of a bacterial cocaine esterase. Nat. Struct. Biol. 9, 17-21.
49. Sun, H., Pang, Y. P., Lockridge, O., and Brimijoin, S. (2002) Re-engineering butyrylcholinesterase as a cocaine hydrolase. Mol. Pharmacol. 62, 220-224.
50. Sun, H., Shen, M. L., Pang, Y. P., Lockridge, O., and Brimijoin, S. (2002) Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. J. Pharmacol. Exp. Ther. 302, 710-716.
51. Turner, J. M., Larsen, N. A., Basran, A., Barbas, C. F. 3rd, Bruce, N. C., Wilson, I. A., and Lerner, R. A. (2002) Biochemical characterization and structural analysis of a highly proficient cocaine esterase. Biochemistry 41, 12297-12307.
52. Chow, M. J., Ambre, J. J., Ruo, T. I., Atkinson, A. J., Bowsher, D. J., and Fischman, M. W. (1985) Kinetics of cocaine distribution, elimination and chronotropic effects. Clin. Pharmacol. Ther. 38, 318-324.
53. Inaba, T. (1989) Cocaine: pharmacokinetics and biotransformation in man. Can. J. Physiol. Pharmacol. 67, 1154-1157.
54. Jeffcoat, A. R., Perez-Reyes, M., Hill, J. M., Sadler, B. M., and Cook, C. E. (1989) Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab. Dispos. 17, 153-159.
55. Sholar, M. B., Mendelson, J. H., Mello, N. K., Siegel, A. J., Kaufman, M. J., Levin, J. M., Renshaw, P. F., and Cohen, B. M. (1998) Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men. J. Clin. Endocrinol. Metab. 83, 966-968.
56. Brogan, W. C. 3rd, Lange, R. A., Glamann, D. B., and Hillis, L. D. (1992) Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann. Intern. Med. 116, 556-561.
57. Kurth, C. D., Shaw, L., and Anday, E. K. (1993) Response of the newborn cerebral circulation to cocaine. Ther. Drug. Monit. 15, 541-545.
58. Covert, R. F., Schreiber, M. D., Tebbett, I. R., and Torgerson, L. J. (1994) Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs. J. Pharmacol. Exp. Ther. 270, 118-126.
59. Schreiber, M. D., Madden, J. A., Covert, R. F., and Torgerson, L. J. (1994) Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries. J. Appl. Physiol. 77, 834-839.
60. Ferreira, S., Crumb, W. J. Jr, Carlton, C. G., and Clarkson, C. W. (2001) Effects of cocaine and its major metabolites on the HERG-encoded potassium channel. J. Pharmacol. Exp. Ther. 299, 220-226.
61. Brzezinski, M. R., Abraham, T. L., Stone, C. L., Dean, R. A., and Bosron, W. F. (1994) Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem. Pharmacol. 48, 1747-1755.
62. Brzezinski, M. R., Spink, B. J., Dean, R. A., Berkman, C. E., Cashman, J. R., and Bosron, W. F. (1997) Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug. Metab. Dispos. 25, 1089-1096.
63. Kamendulis, L. M., Brzezinski, M. R., Pindel, E. V., Bosron, W. F., and Dean, R. A. (1996) Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J. Pharmacol. Exp. Ther. 279, 713-717.
64. Warner, A., and Norman, A. B. (2000) Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo clarification. Ther. Drug. Monit. 22, 266-270.
65. Hearn, W. L., Flynn, D. D., Hime, G. W., Rose, S., Cofino, J. C., Mantero-Atienza, E., Wetli, C. V., and Mash, D. C. (1991) Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J. Neurochem. 56, 698-701.
66. Boyer, C. S., and Petersen, D. R. (1992) Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J. Pharmacol. Exp. Ther. 260, 939-946.
67. Landry, M. J. (1992) An overview of cocaethylene, an alcohol-derived, psychoactive, cocaine metabolite. J. Psychoactive Drugs 24, 273-276.
68. Bailey, D. N. (1993) Serial plasma concentrations of cocaethylene, cocaine, and ethanol in trauma victims. J. Anal. Toxicol. 17, 79-83.
69. Bailey, D. N. (1996) Comprehensive review of cocaethylene and cocaine concentrations in patients. Am. J Clin. Pathol. 106, 701-704.
70. Bailey, D. N. (1999) Amitriptyline and procainamide inhibition of cocaine and cocaethylene degradation in human serum in vitro. J. Anal. Toxicol. 23, 99-102.
71. Perez-Reyes, M., Jeffcoat, A. R., Myers, M., Sihler, K., and Cook, C. E. (1994) Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. Psychopharmacology 116, 428-432.
72. Xu, Y. Q., Crumb, W. J. Jr, and Clarkson, C. W. (1994) Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J. Pharmacol. Exp. Ther. 284, 10-18.
73. Gerritsen, V. B. (2002) Rhodococcus: nature's junkie. Protein Spotlight 27 (web site: http://us.expasy.org/spotlight/articles/sptlt027).
74. Nicholls, A., Sharp, K. A., and Honig, B. (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Gen. 11, 281-296.